Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2014 version)].
Sun Y, Guan Z, Liao M, Yu X, Wang C, Wang J, Niu X, Shi Y, Zhi X, Liu Y, Liu M, Zhang Y, Yang Y, Shen J, Chen G, Zhou Q, Zhou C, Guo Q, Tang L, Duan J, Liang J, Zhang Y, Cheng Y. Sun Y, et al. Among authors: zhi x. Zhongguo Fei Ai Za Zhi. 2014 Feb;17(2):57-72. doi: 10.3779/j.issn.1009-3419.2014.02.01. Zhongguo Fei Ai Za Zhi. 2014. PMID: 24581154 Free PMC article. Review. Chinese. No abstract available.
[Guideline of surgical practice for non-small cell lung cancer based staging].
Wu Y, Zhou Q, Liao M, Jiang G, Zhang M, Zhang X, Wang J, Zhi X, Chen G, Wang S, Yang X, Sun Y; Chinese Society of Lung Cancer of CACA. Wu Y, et al. Among authors: zhi x. Zhongguo Fei Ai Za Zhi. 2004 Oct 20;7(5):399-403. doi: 10.3779/j.issn.1009-3419.2004.05.06. Zhongguo Fei Ai Za Zhi. 2004. PMID: 21244791 Free article. Chinese.
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study.
Zhou C, Wu YL, Chen G, Feng J, Liu XQ, Wang C, Zhang S, Wang J, Zhou S, Ren S, Lu S, Zhang L, Hu C, Hu C, Luo Y, Chen L, Ye M, Huang J, Zhi X, Zhang Y, Xiu Q, Ma J, Zhang L, You C. Zhou C, et al. Among authors: zhi x. Lancet Oncol. 2011 Aug;12(8):735-42. doi: 10.1016/S1470-2045(11)70184-X. Epub 2011 Jul 23. Lancet Oncol. 2011. PMID: 21783417 Clinical Trial.
Chinese guidelines on the diagnosis and treatment of primary lung cancer (2011).
Zhi XY, Wu YL, Bu H, Cheng G, Cheng Y, Du X, Han BH, Jiang GN, Jiao SC, Liu DR, Liu LX, Lu Y, Ma SL, Shi YK, Wang CL, Wang J, Wang TY, Yang Y, Zhou QH; Lung Cancer Diagnosis and Treatment Expert Panel of the Chinese Ministry of Health. Zhi XY, et al. J Thorac Dis. 2012 Feb;4(1):88-101. doi: 10.3978/j.issn.2072-1439.2010.08.01. J Thorac Dis. 2012. PMID: 22295172 Free PMC article. No abstract available.
Clinical pathway for surgical treatment of primary lung cancer 
(2012 Edition).
Zhi XY, He JX, Li H, Zhang X, Jiang GN, Zhao H, Liu LX, Liu DR, Li SQ, Li J, Zhou QH, Wang Q, Wang RW, Fu JH, Xu L, Zhang LY, Zhou NK, Xu SF; Expert Panel of Thoracic Surgery; Expert Committee on Clinical Pathway Review; Ministry of Health of the People’s Republic of China. Zhi XY, et al. J Thorac Dis. 2012 Dec;4(6):671-5. doi: 10.3978/j.issn.2072-1439.2012.10.15. J Thorac Dis. 2012. PMID: 23205300 Free PMC article. No abstract available.
1,107 results